1. Overview of the updated ECDC/EMCDDA guidance on the prevention and control of infectious diseases among people who inject drugs

Wednesday, 23 November, 2022 - 13:20 to 14:50
Networking zone 3 (N3)

Abstract

The updated joint guidance focuses on the prevention and control of hepatitis B, hepatitis C, HIV/AIDS and tuberculosis (TB) and is intended for use by policy makers and public health/social programme planners. This presentation will cover the key recommendations in 2011, the rationale and process for the update, the updated evidence, and the next steps.

Speakers

Bergenstrom
Anne
  • Scientific health analyst,
  • EMCDDA,
  • Lisbon,
  • Portugal
Sandberg
Janelle
  • Scientific officer,
  • European Centre for Disease Prevention and Control (ECDC),
  • Solna,
  • Sweden

Presentation files

23 107 1320 Anne Bergenstrom_v1.0.pdf618.22 KBDownload

Type

Tracks

Part of session

Prevention and control of infectious diseases among people who inject drugs: New evidence within the updated guidance from the ECDC and the EMCDDA